IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,940,642 | +17.5% | 646,295 | +147.5% | 0.03% | -2.9% |
| Q3 2022 | $2,502,000 | -54.6% | 261,134 | -47.7% | 0.04% | -58.8% |
| Q2 2022 | $5,517,000 | +77.3% | 499,770 | +167.5% | 0.08% | +70.0% |
| Q1 2022 | $3,111,000 | -73.7% | 186,864 | -69.8% | 0.05% | -70.4% |
| Q4 2021 | $11,811,000 | +158.1% | 618,703 | +233.4% | 0.17% | +125.3% |
| Q3 2021 | $4,576,000 | -47.9% | 185,552 | -33.1% | 0.08% | -61.5% |
| Q1 2021 | $8,786,000 | +777.7% | 277,523 | +1186.4% | 0.20% | +622.2% |
| Q4 2020 | $1,001,000 | -84.7% | 21,574 | -89.1% | 0.03% | -87.4% |
| Q3 2020 | $6,541,000 | -22.1% | 198,684 | -29.2% | 0.21% | -64.3% |
| Q1 2020 | $8,397,000 | +112.7% | 280,498 | +96.6% | 0.60% | +272.7% |
| Q4 2019 | $3,948,000 | – | 142,641 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |